Positron emission tomography (PET) provides a non-invasive method to measure biological
processes that are relevant to atherosclerosis, including arterial inflammation and …

FDG is a tracer for visualizing glucose metabolism. PET/CT using FDG is widely used for the
diagnosis of cancer, because glycolysis is elevated in cancer cells. Similarly, active …

Objective Recent large-scale randomised trials demonstrate that immunomodulators reduce
cardiovascular (CV) events among the general population. However, it is uncertain whether …

Cardiovascular diseases are the leading cause of death not only in Europe but also in the
rest of the World. Preventive measures, however, often fail and cardiovascular disease may …

Rationale: GlycA, an emerging inflammatory biomarker, predicted cardiovascular events in
population-based studies. Psoriasis, an inflammatory disease associated with increased …

Rheumatic diseases are various painful conditions that affect joints, bones, cartilage,
tendons, ligaments, and muscles. Arthritis is a typical condition of rheumatic disease …

In diagnosing and following patients with acute aortic syndromes and thoracic aortic
aneurysms, high-quality imaging of the thoracic aorta is indispensable. Mainstay modalities …

GlycA is a biomarker of systemic inflammation, quantifying both the protein concentrations
and glycosylation states of several acute phase proteins. GlycA has been shown to be …

Objective RA is associated with higher risk of cardiovascular (CV) disease. Ongoing
systemic inflammation is presumed to accelerate atherosclerosis by increasing inflammation …

Inflammation is known to play a significant role in the process of atherogenesis and
cardiovascular disease (CVD). Indeed, patients with chronic inflammatory diseases are at …